As Ozempic Slims Waistlines, It’s Also Bulking Up Biomanufacturing Space

The eye-watering profit projections of a new class of weight-loss drugs has become a focus of biotech and Big Pharma, with companies jockeying to bring new drugs to market and expand production capacity for those that already have approval.
Even as the…
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks